As these patients gained resistance to therapies either by loss of AR-signaling dependence or AR expression [7,8,9], this highly aggressive and advanced stage of PCa has limited treatment options as even cytotoxic chemotherapy offers little survival benefit [10]. Here, AR is linked to posterior cortical atrophy.